The AESOP Trial: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Obeticholic Acid in Patients with Primary Sclerosing Cholangitis

被引：0
|
作者：
Kowdley, Kris V. [2 ]
Bowlus, Christopher L. [3 ]
Levy, Cynthia [4 ]
Vuppalanchi, Raj [5 ]
Floreani, Annarosa [6 ]
Andreone, Pietro [7 ]
LaRusso, Nicholas F. [8 ]
Shrestha, Roshan [9 ]
Trotter, James [1 ]
Goldberg, David S. [10 ]
Rushbrook, Simon [11 ]
Hirschfield, Gideon M. [12 ]
Van Biene, Courtney [13 ]
Pencek, Richard [13 ]
MacConell, Leigh [13 ]
Shapiro, David [13 ]
机构：
[1] Baylor Univ, Div Transplant Hepatol, Dallas, TX USA
[2] Swedish Med Ctr, Seattle, WA USA
[3] Univ Calif Davis, Div Gastroenterol & Hepatol, Sacramento, CA 95817 USA
[4] Univ Miami, Miller Sch Med, Div Hepatol, Miami, FL 33136 USA
[5] Indiana Univ Sch Med, Indianapolis, IN 46202 USA
[6] Univ Padua, Padua, Italy
[7] Univ Bologna, Bologna, Italy
[8] Mayo Clin, Dept Med, Div Gastroenterol & Hepatol, Rochester, MN USA
[9] Piedmont Transplant Inst, Dept Transplantat, Atlanta, GA USA
[10] Univ Penn, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA
[11] Norwich Med Sch, Fac Med & Hlth Sci, Norwich, Norfolk, England
[12] Univ Birmingham, Ctr Liver Res, NIHR BRU, Birmingham, W Midlands, England
[13] Intercept Pharmaceut Inc, San Diego, CA USA
来源：
HEPATOLOGY | 2017年 / 66卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
LB-2
引用
收藏
页码：1254A / 1255A
页数：2
相关论文
共 50 条
  • [21] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF URSODEOXYCHOLIC ACID IN PRIMARY BILIARY-CIRRHOSIS
    COMBES, B
    CARITHERS, RL
    MADDREY, WC
    LIN, DY
    MCDONALD, MF
    WHEELER, DE
    EIGENBRODT, EH
    MUNOZ, SJ
    RUBIN, R
    GARCIATSAO, G
    BONNER, GF
    WEST, AB
    BOYER, JL
    LUKETIC, VA
    SHIFFMAN, ML
    MILLS, AS
    PETERS, MG
    WHITE, HM
    ZETTERMAN, RW
    ROSSI, SS
    HOFMANN, AF
    MARKIN, RS
    HEPATOLOGY, 1995, 22 (03) : 759 - 766
  • [22] ETANERCEPT IN ALZHEIMER DISEASE: A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, PHASE 2 TRIAL
    Tufan, Ayse N.
    Tufan, Fatih
    NEUROLOGY, 2015, 85 (23) : 2083 - 2084
  • [23] Control: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Investigating the Effects of Obeticholic Acid and Atorvastatin Treatment on Lipoprotein Metabolism in Patients with Nonalcoholic Steatohepatitis
    Pockros, Paul J.
    Fuchs, Michael
    Freilich, Bradley L.
    Schiff, Eugene R.
    Kohli, Anita
    Lawitz, Eric J.
    Hellstern, Paul A.
    Cohen, David E.
    Owens-Grillo, Janet
    Van Biene, Courtney
    Shringarpure, Reshma
    MacConell, Leigh
    Shapiro, David A.
    HEPATOLOGY, 2018, 68 : 951A - 952A
  • [24] A PHASE 2b/3 RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL FOR TREATMENT OF PRIMARY BILIARY CHOLANGITIS (PBC) WITH SETANAXIB: OBJECTIVES AND STUDY DESIGN
    Jones, David
    Carlsson, Stefan
    Von Reedtz, Sari
    Levy, Cynthia
    HEPATOLOGY, 2022, 76 : S1461 - S1462
  • [25] A Randomized, Double-Blind, Placebo-Controlled Trial of Fluvoxamine in Patients With Schizophrenia A Preliminary Study
    Niitsu, Tomihisa
    Fujisaki, Mihisa
    Shiina, Akihiro
    Yoshida, Taisuke
    Hasegawa, Tadashi
    Kanahara, Nobuhisa
    Hashimoto, Tasuku
    Shiraishi, Tetsuya
    Fukami, Goro
    Nakazato, Michiko
    Shirayama, Yukihiko
    Hashimoto, Kenji
    Iyo, Masaomi
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2012, 32 (05) : 593 - 601
  • [26] Applicability of Press Needles to a Double-blind Trial A Randomized, Double-blind, Placebo-controlled Trial
    Miyazaki, Shougo
    Hagihara, Akihito
    Kanda, Ryo
    Mukaino, Yoshito
    Nobutomo, Koichi
    CLINICAL JOURNAL OF PAIN, 2009, 25 (05): : 438 - 444
  • [27] Aprepitant in the Treatment of Subacute Sclerosing Panencephalitis: A Randomized, Double-Blind, Placebo-Controlled Study
    Oncel, Ibrahim
    Sancar, Mesut
    Konuskan, Bahadir
    Arioz, Filiz
    Tezcan, Songul
    Arman-Kandirmaz, Emine
    Parlak, Safak
    Gumeler, Ekim
    Anlar, Banu
    PEDIATRIC NEUROLOGY, 2020, 110 : 59 - 63
  • [28] A randomized double-blind placebo-controlled trial of thioctic acid in migraine prophylaxis
    Magis, Delphine
    Ambrosini, Anna
    Sandor, Peter
    Jacquy, Jean
    Laloux, Patrice
    Schoenen, Jean
    HEADACHE, 2007, 47 (01): : 52 - 57
  • [29] RANDOMIZED, DOUBLE-BLIND CONTROLLED TRIAL OF HIGH-DOSE URSODEOXYCHOLIC ACID (UCDA) FOR PRIMARY SCLEROSING CHOLANGITIS (PSC)
    Lindor, Keith D.
    Enders, Felicity B.
    Schmoll, Jeffrey A.
    Hoskin, Tanya L.
    Jorgensen, Roberto A.
    Petz, Janice L.
    Keach, Jill C.
    Kowdley, Kris V.
    Mooney, Jody C.
    Luketic, Velimir A.
    Sargeant, Carol C.
    Harrison, M. Edwyn
    Braaten, Julie K.
    McCashland, Timothy M.
    Bernord, Tamara
    Befeler, Alex
    King, Debra L.
    Harnois, Denise M.
    Miceli, Ellen L.
    HEPATOLOGY, 2008, 48 (04) : 378A - 378A
  • [30] EFFICACY AND SAFETY OF OBETICHOLIC ACID IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS: AN ANALYSIS OF THE ITALIAN PATIENTS FROM A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED STUDY
    Floreani, A.
    Andreone, P.
    Invernizzi, P.
    Mazzella, G.
    Owens-Grillo, J.
    Malecha, E. Smoot
    Macconell, L.
    DIGESTIVE AND LIVER DISEASE, 2017, 49 : E74 - E74
12345